title: Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (<or=5 mm) choroidal melanoma lesions.
abstract: The aim of this study was to compare dosimetric parameters between iodine-125 ((125)I) and ruthenium-106 ((106)Ru) plaques of similar sizes in the treatment of choroidal melanomas. The study design included retrospective double planning of each case. 26 consecutive patients with choroidal melanomas measuring 5 mm or less in thickness were included. Dose distributions were calculated using Plaque Simulator treatment-planning software for a prescription of 85 Gy to the tumour apex. Doses to the outer sclera, lens, fovea and optic disc were obtained for each case using appropriately sized plaques of each isotope. Statistical inferences were made using the non-parametric Wilcoxon signed rank test. The mean dose to the macula, disc and lens was 18%, 53% and 89% less, respectively, with (106)Ru than with (125)I. Scleral doses were greater for (106)Ru. The use of collaborative ocular melanoma study dosimetry results in even higher mean doses to the macula, disc, lens and sclera. Two-dimensional dose distributions and dose volume histograms demonstrated the increase in dose outside the tumour volume using (125)I. This comparison shows that, for tumours not exceeding 5 mm in thickness, the use of (106)Ru plaques has the potential to reduce the radiation dose to nearby normal structures and possibly lower the risk of radiation-induced visual loss.
authors.affiliation: Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. wilkina@ccf.org
authors.forename: D A
authors.initials: DA
authors.lastname: Wilkinson
authors.forename: M
authors.initials: M
authors.lastname: Kolar
authors.forename: P A
authors.initials: PA
authors.lastname: Fleming
authors.forename: A D
authors.initials: AD
authors.lastname: Singh
mesh_terms: D002830:Choroid Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000532:radiotherapy*; D011835:Radiation Protection / Q000379:methods; D011874:Radiometry; D012107:Research Design; D012189:Retrospective Studies; D012429:Ruthenium Radioisotopes / Q000627:therapeutic use*; D012984:Software; D014786:Vision Disorders / Q000517:prevention & control; D014792:Visual Acuity
chemical_list: D007457:Iodine Radioisotopes; D012429:Ruthenium Radioisotopes